Literature DB >> 1752858

Awakening the sleeping giant: anatomy and plasticity of the brain serotonergic system.

E C Azmitia1, P M Whitaker-Azmitia.   

Abstract

The serotonergic neurons of the mammalian brain comprise one of the most expansive chemical systems known. The cell bodies are largely confined to the midline (raphe) region of the brain stem in two general clusters: a superior group that consists of the dorsal raphe nucleus (B-7 and B-6), median raphe nucleus (B-8 and B-5), caudal linear nucleus (rostral B-8), and supralemniscal nucleus (B-9), and an inferior group that consists of nucleus raphe obscurus (B-2), nucleus raphe pallidus (B-1), nucleus raphe magnus (B-3), ventral lateral medulla (B-1/B-3), and the area postrema. The axons from these cells project throughout the neuroaxis from the spinal cord to the olfactory bulb and from the cerebral cortex to the hypothalamus. The development of this giant system begins very early in gestation and is influenced by a variety of growth regulatory factors, including the astroglial protein S-100 beta. Evidence will be presented that the serotonergic system plays a major role in the maturation of the brain by interacting with the 5-HT1A receptors which are most dense during these early developmental periods. The 5-HT1A receptor is located on both neurons and astrocytes, and in the latter cells may serve to stimulate release of S-100 beta. The developmental role of 5-HT appears to become dormant as the brain matures, and during aging and Alzheimer's disease, 5-HT receptors are significantly depressed. However, specific damage to 5-HT fibers in the adult brain by 5,7-dihydroxytryptamine produces a sharp fall in the levels of 5-HT which seems to reactivate the developmental signals in the brain. Not only are the serotonergic fibers encouraged to sprout and expand their territory, but the stimulation of the astrocytic growth factor by a 5-HT1A agonist is reinstated. The ability to recall developmental processes in the adult brain by interrupting the 5-HT fibers may provide important tools for understanding and treating the aged brain.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1752858

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  29 in total

Review 1.  The potential role of serotonin in the pathogenesis of neurocardiogenic syncope and related autonomic disturbances.

Authors:  B P Grubb; B J Karas
Journal:  J Interv Card Electrophysiol       Date:  1998-12       Impact factor: 1.900

Review 2.  The unknown mechanism of the overtraining syndrome: clues from depression and psychoneuroimmunology.

Authors:  Lawrence E Armstrong; Jaci L VanHeest
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

Review 3.  The dimensional approach to clinical psychopharmacology: a polysemous concept.

Authors:  P Baruch; M J Filteau; R H Bouchard; E Pourcher; P Vincent; R Jouvent
Journal:  J Psychiatry Neurosci       Date:  1992-06       Impact factor: 6.186

4.  Chronic administration of citalopram in olfactory bulbectomy rats restores brain 5-HT synthesis rates: an autoradiographic study.

Authors:  Shu Hasegawa; Arata Watanabe; Khanh Q Nguyen; Guy Debonnel; Mirko Diksic
Journal:  Psychopharmacology (Berl)       Date:  2004-12-24       Impact factor: 4.530

5.  The unusual response of serotonergic neurons after CNS Injury: lack of axonal dieback and enhanced sprouting within the inhibitory environment of the glial scar.

Authors:  Alicia L Hawthorne; Hongmei Hu; Bornali Kundu; Michael P Steinmetz; Christi J Wylie; Evan S Deneris; Jerry Silver
Journal:  J Neurosci       Date:  2011-04-13       Impact factor: 6.167

6.  Interactions between chemokine and mu-opioid receptors: anatomical findings and electrophysiological studies in the rat periaqueductal grey.

Authors:  Silke Heinisch; Jonathan Palma; Lynn G Kirby
Journal:  Brain Behav Immun       Date:  2010-10-23       Impact factor: 7.217

7.  Three-dimensional surface mapping of the caudate nucleus in late-life depression.

Authors:  Meryl A Butters; Howard J Aizenstein; Kiralee M Hayashi; Carolyn C Meltzer; Jamie Seaman; Charles F Reynolds; Arthur W Toga; Paul M Thompson; James T Becker
Journal:  Am J Geriatr Psychiatry       Date:  2009-01       Impact factor: 4.105

8.  Substrate regulation of serotonin and dopamine synthesis in Drosophila.

Authors:  Chandra M Coleman; Wendi S Neckameyer
Journal:  Invert Neurosci       Date:  2004-10-06

Review 9.  Implications of genetic research on the role of the serotonin in depression: emphasis on the serotonin type 1A receptor and the serotonin transporter.

Authors:  Alexander Neumeister; Theresa Young; Juergen Stastny
Journal:  Psychopharmacology (Berl)       Date:  2004-07-13       Impact factor: 4.530

Review 10.  Recent progress in understanding the pathophysiology of post-traumatic stress disorder: implications for targeted pharmacological treatment.

Authors:  Christopher R Bailey; Elisabeth Cordell; Sean M Sobin; Alexander Neumeister
Journal:  CNS Drugs       Date:  2013-03       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.